Chandru has over 25 years of experience in leading and managing bio pharmaceutical businesses across diverse geographies and segments. He has a proven track record having managed P&Ls and Strategy and Business Development globally. His varied experience straddles start-ups, acquired companies and multiple product segments. In his last role as Senior Vice President – International for Lupin, he headed business operations spread across emerging markets in Asia, Latin America and Africa with directorial responsibility in multiple subsidiaries. Prior to this, Chandru has worked with Wockhardt as General Manager for emerging markets.
At Cipla, he has played a leadership role in its transformation from a “partner led” business model to a business that stands on innovation and meaningful commercial presence in key markets driving initiatives across emerging markets, biotechnology, specialty and consumer health. Chandru championed the creation of a business and innovation incubator called Cipla New Ventures (CNV), where it is nurturing in venture style, businesses that require unique entrepreneurial and start up like eco systems. This included investments in Consumer health, regenerative medicine, drug repurposing and Bio-similar drugs. Cipla Health was recently spun out as a FMCG style consumer health company with a Series A investment from a marquee investor, Fidelity. Its investments in Chase Pharma, an Alzheimer’s company, saw a successful.
His current focus is to build a Branded Specialty business in the US Chandru is an alumnus of IIT Mumbai and IIFT New Delhi.